Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More

Hester Biosciences launches PPR vaccine and Goat Pox vaccine

Posted On: 2015-03-22 09:47:14

Hester Biosciences Limited, India's leading animal biological & health care company, launches its PPR (Peste Des Petits Ruminants) vaccine and Goat Pox vaccine. With the launch of these vaccines as well as being the second largest poultry vaccine manufacturer in India, Hester has positioned itself to capitalise on upcoming opportunities in the animal health care industry globally as well as in India.

PPR vaccine is to be given annually to sheep and goats. PPR disease causes dysentery and death of the animal. It is therefore a disease of high economical importance worldwide. The total targeted population of sheep and goat for PPR vaccine in the world is 145 crores. In India, the targeted population is 20 crores.

Mr. Rajiv Gandhi, CEO & MD, Hester Biosciences Ltd said "The world market for PPR vaccine is slated to be for INR 300 crores annually. The Indian market is slated to be INR 40 crores annually. The PPR vaccine will contribute toward also the disease eradication programs of the Government of India. Hester is also the first company in India to manufacture the Goat Pox vaccine. This vaccine is to be given annually to goats. Goat Pox disease causes death in Goats."

The total targeted population of goats for Goat Pox vaccine in the world is 97 crores, with 50% of that population being in Asia. In India, the targeted population is 14 crores. The world market for Goat Pox vaccine is slated to be for INR 500 crores annually. The Indian market is slated to be INR 70 crores annually.

Apart from poultry and large animal vaccines, the company has recently forayed into poultry health products and large animal health products. These four verticals put together will underpin Hester's identity as a strong animal health company, addressing all segments in the animal health care sector. Company currently manufactures and markets veterinary vaccines and health products for India and global markets. Company's product portfolio comprises of over 47 vaccines and over 35 health products.

"We have already invested INR 7 crores in plant and machinery for stepping up our vaccine production capacity as well as towards increasing our vaccine range. We hope to invest another INR 18 crore in the next couple of years. This expansion will help us to meet rising demand from domestic and export markets" said Mr. Gandhi.

"We at Hester aspire towards improving the health of animals by diagnosing & preventing diseases. Our R&D department is involved in the development of on new products and vaccines for preventing diseases. Company currently exports to eight countries and product registration activities are going on in over 20 countries. In the next 3-4 years international business would be equal or more than the domestic sales" added Mr. Gandhi.

The global animal healthcare market stands at around $ 22 billion, off which the market size in India is estimated to be $ 375 million. India has a huge poultry and cattle population and with growing awareness, market is expected to see a multi-fold increase in years to come.

Hester Biosciences is a company manufacturing animal vaccines and health products with a focus on R&D towards developing next generation recombinant vaccines. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art manufacturing facility, having WHO-GMP, ISO 9001, ISO 14001, OHSAS 18001 & GLP certifications.

For the FY 2013-14, the company reported net profit of INR 10.09 crore on revenue of INR 69.05 crore. "Going forward we expect to cross INR 200 crore turnover by FY 16-17," said Mr. Gandhi. The company is listed on BSE and NSE.

Shares of HESTER BIOSCIENCES LTD. was last trading in BSE at Rs.473.7 as compared to the previous close of Rs. 485.2. The total number of shares traded during the day was 19565 in over 893 trades.

The stock hit an intraday high of Rs. 504 and intraday low of 455. The net turnover during the day was Rs. 9199487.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Royal Orchid Hotels Ltd to consider second quarter results on Nov 2, 2017
Amarjothi Spinning Mills Ltd to announce Q2 results on Oct 30, 2017
Ramco Systems sets up subsidiary in Indonesia
NIIT strengthens Global Retail Business arm to drive Digital Transformation
Karnataka Bank launches its revamped corporate website
BMB Investment Bank, Bahrain selects TCS BaNCS for Treasury to drive innovation and enhance customer experience
Subex User Conference 2017 set to tackle the operational challenges of Digitalisation
TCS Recognized as a Leader in Life Sciences Social Media Analytics by IDC MarketScape
Banks catch up with Amazon and Netflix as iGTB's CBX 18 launches the contextual revolution
Zydus receives final approval from the USFDA for Allopurinol Tablets USP
TCS Launches 'Connected Clinical Trials' Platform on its Advanced Drug Development Suite
Persistent Systems amongst the leading players in 'Zinnov Zones 2017 - Digital Services' Report
Zydus receives final approval from the USFDA for Desvenlafaxine Extended-Release Tablets
CARE assigns ratings to commercial paper programme of Surya Roshni Ltd
Shiva Cement Ltd calls for Board Meeting on Oct 27, 2017
Weizmann Forex Ltd to consider quarterly results on Oct 31, 2017
Capital First Ltd to announce Q2 results on Oct 31, 2017
Shriram City Union Finance Ltd to consider second quarter results on Nov 2, 2017
INOX Leisure Ltd commences operations of Video Cinema at Atrial Mall, Worli
Reliance Home Finance Ltd to approve Q2 results on Oct 30, 2017
K P R Mill Ltd calls for Board Meeting on Oct 30, 2017
Ultramarine & Pigments Ltd to consider 2nd quarter results on Nov 11, 2017
VA Tech Wabag Ltd calls for Board Meeting on Nov 8, 2017
Beardsell Ltd appoints Mrs. Vijayalakshmi Ravindranath as Independent Director
GMR Hyderabad International Airport to allot $350 Mn of 4.25% senior secured fixed rate notes
Apollo Hospitals Enterprise Ltd to announce Q2 results on Nov 13, 2017
Frontline Securities Ltd appoints CFO
Megri Soft Ltd calls for Board Meeting On October 28, 2017
Ind Bank Housing Ltd announces resignation of company secretary
Jammu & Kashmir Bank to consider 2nd quarter results on Oct 27, 2017
VXL Instruments Ltd calls for Board Meeting on Oct 31, 2017
Redington India Ltd calls for Board Meeting on Oct 31, 2017
IP Rings Ltd calls for Board Meeting on Nov 8, 2017
ESAB India Ltd to announce second quarter results on Nov 9, 2017
Sundaram Brake Linings Ltd calls for Board Meeting on Nov 9, 2017
Archana Software Ltd to announce quarterly results on Oct 30, 2017
TTK Healthcare Ltd to approve 2nd quarter results on Nov 8, 2017
OnMobile Global Ltd calls for Board Meeting On October 30, 2017
Britannia Industries Ltd to consider Q2 results on Nov 12, 2017
InterGlobe Aviation Ltd updates on investments in mutual funds
Gyan Developers & Builders Ltd calls for Board Meeting on Oct 25, 2017
Divi's Laboratories Ltd calls for Board Meeting on Oct 31, 2017
Andhra Bank to approve Q2 results on Nov 2, 2017
Srestha Finvest Ltd calls for Board Meeting on Nov 10, 2017
Loyal Textile Mills Ltd appoints Ms.Vishala Ramswami as CEO
Tanla Solutions to announce 2nd quarter results on Oct 31, 2017
Automobile Corporation of Goa Ltd to consider Q2 results on Oct 30, 2017
Dhanlaxmi Bank Ltd to consider Q2 results on Nov 13, 2017
Page Industries Ltd fixes Nov 17, 2017 as record date for interim dividend
ONGC fixes Nov 6, 2017 as record date for first interim dividend


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017